Exhibit 10.7


 





AMENDED AND RESTATED
STOCKHOLDERS AGREEMENT


 


This
AMENDED AND RESTATED STOCKHOLDERS AGREEMENT, dated as of March 27, 2013, by and among (i) Sequential Brands Group, Inc., a Delaware
corporation, formerly known as People’s Liberation, Inc. (the “Company”), (ii) TCP WR Acquisition, LLC
(“Tengram”), and (iii) any other holder of common stock of the Company that may become a party to this Agreement
after the date and pursuant to the terms hereof (collectively with Tengram, the “Stockholders”). Capitalized
terms used herein without definition shall have the meanings set forth in Section 3.1.


 


RECITALS


 


A.Pursuant
to a Securities Purchase Agreement, dated as of February 2, 2012 (the “Securities Purchase Agreement”), between
the Company and Tengram, Tengram purchased $14,500,000 in principal amount of Convertible Debentures along with 14,500 shares of
the Company’s Preferred Stock pursuant to which Tengram has the right to vote on all matters on which holders of common stock,
$0.001 par value per share, of the Company (the “Common Stock” and together with all other voting equity of
the Company, including the Preferred Stock, the “Equity Securities”) have the right to vote (such transaction,
the “Purchase”, and the consummation of the Purchase, the “Closing”).


 


B. The
Company, Tengram and Colin Dyne, an individual (“Dyne”), previously entered into that certain Stockholders Agreement,
dated as of February 22, 2012 (the “Original Agreement”) and desire to amend and restate the Original Agreement
as provided herein (including the removal of Dyne as a party thereto).


 


NOW,
THEREFORE, in consideration of the mutual agreements contained herein, the Original Agreement is hereby amended and restated in
its entirety as follows:


 


ARTICLE
I 


GOVERNANCE
AND MANAGEMENT OF THE COMPANY


 


1.1 Board Nominee
Agreement.


 


(a)Tengram
Nominees. Subject to the terms and conditions of this Section 1, in connection with any director nominees to be submitted
to the Company’s stockholders for election (whether at a stockholders’ meeting or by written consent), Tengram shall
have the right to nominate a number of nominees for director such that the number of directors that will be serving on the Board
(determined immediately following the election of directors and assuming that the director nominee(s) designated by Tengram are
elected to the Board) that have been appointed or nominated by Tengram equals three (3). The Company agrees to include any director
nominees designated by Tengram (each, a “Tengram Nominee” and collectively, the “Tengram Nominees”)
pursuant to this Section 1.1 in the slate of the Board’s nominees presented to the Company’s stockholders for election.
Messrs. Sweedler, Eby and Gersten have been appointed to the Board as Tengram’s initial director designees.


 






    	1



    	 



    

 


(b)Other
Nominees. All Board nominees other than those described in Section 1.1(a) above, if any, to be presented to the Company’s
stockholders for election shall be designated by the full Board of Directors, acting by majority vote.


 


(c)Staggered
Board. The parties acknowledge that the Company currently has a staggered Board of Directors, and that it is expected that
Tengram always will have one (1) director serving as a Class I Director, Class II Director and Class III Director, and that Tengram
always will have the right to nominate one (1) director for election to the Board at each annual meeting of stockholders.


 


(d)Existing
Board Nominee Agreement. The parties acknowledge that the Company is party to that certain Preemptive Rights and Board Nominee
Agreement, dated as of October 1, 2011, by and among the Company, Tennman WR-T, Inc. (“TWR”), and Alvin Gossett
(the “Preemptive Rights and Board Nominee Agreement”), pursuant to which TWR has rights to appoint, and has
appointed, Alvin Gossett to serve on the Board.


 


1.2Qualification
for Service on the Board. Tengram’s right to designate a Tengram Nominee as a Board nominee pursuant to Section 1.1(a)
above, and the Company’s obligations with respect thereto, is conditional upon the following:


 


(a)the
Tengram Nominee consenting in writing to serve as director if elected;


 


(b)the
Tengram Nominee providing the Company with all information reasonably required for a board appointment as requested by the Company
from time to time concerning the Tengram Nominee and his nomination, including his completion of the Company’s non-employee
director questionnaire and providing the Company with all other information that the Company is required to include in its proxy
statement with respect persons nominated by the Company’s Board of Directors;


 


(c)the
Tengram Nominee complying at all times while serving on the Company’s Board of Directors, with all applicable laws including,
without limitation, federal securities laws and state fiduciary duty laws; and


 


(d)the
Tengram Nominee complying at all times while serving on the Company’s Board of Directors, with the Company’s policies
applicable to all non-employee directors of the Company, including, without limitation, insider trading policies, confidentiality
agreements, and codes of ethics.


 






    	2



    	 



    

 


If at any time a Tengram Nominee fails
to comply with his obligations under this Section 1.2, the Company, upon approval of the Board, acting by majority vote, may provide
the Tengram Nominee with written notice of his failure to so comply, which notice shall specify in reasonable detail the Tengram
Nominee’s failure to so comply. If the Tengram Nominee does not cure such failure within fifteen (15) days following the
date written notice is provided to the Tengram Nominee, then the Tengram Nominee shall no longer qualify for service on the Company’s
Board of Directors, the Tengram Nominee shall immediately tender to the Board his resignation as a director of the Company, which
resignation shall be effective upon receipt, and Tengram shall not have the right to again nominate such person as a Tengram Nominee
for a period of three (3) years following such resignation.


 


1.3Vacancies
on the Board. If a vacancy is created on the Board as a result of the death, disability, retirement, resignation or removal
of any Tengram Nominee, then Tengram shall have the right to designate such person’s replacement, and the Board shall fill
the vacancy caused by such death, disability, retirement, resignation or removal with the person so designated as the replacement.


 


1.4Company Actions.
The Company shall take all necessary and desirable actions within its control (including, without limitation, calling special board
and stockholder meetings and approval of amendments and/or restatements of the Company’s certificate of incorporation or
by-laws), to cause the election, removal and replacement of directors and members of committees in the manner contemplated in,
and otherwise give the fullest effect possible to, the provisions of this ARTICLE I.


 


1.5Approvals.Except
as required by Applicable Law, all actions requiring the approval of the Board shall be approved by a majority of the directors
present at any duly convened Board meeting or by unanimous written consent of the directors without a meeting, in each case in
accordance with the provisions of the Delaware General Corporation Law and the by-laws of the Company.


 


1.6Corporate
Opportunities. (i) No Stockholder and no member, manager, partner or Affiliate of any Stockholder or their respective officers,
directors, employees or agents (any of the foregoing, a “Stockholder Group Member”) shall have any duty to
communicate or present an investment or business opportunity or prospective economic advantage to the Company or any of its Subsidiaries
in which the Company or one of its Subsidiaries may, but for the provisions of this Section 1.6, have an interest or expectancy
(“Corporate Opportunity”), and (ii) no Stockholder or any Stockholder Group Member (even if also an officer
or director of the Company) will be deemed to have breached any fiduciary or other duty or obligation to the Company by reason
of the fact that any such Person pursues or acquires a Corporate Opportunity for itself or its Affiliates or directs, sells, assigns
or transfers such Corporate Opportunity to another Person or does not communicate information regarding such Corporate Opportunity
to the Company. The Company, on behalf of itself and its Subsidiaries, renounces any interest in a Corporate Opportunity and any
expectancy that a Corporate Opportunity will be offered to the Company, provided that the Company does not renounce any interest
or expectancy it may have in any Corporate Opportunity that is offered to an officer of the Company whether or not such individual
is also a director or officer of a Stockholder, if such opportunity is expressly offered to such Person in his or her capacity
as an officer of the Company and the Stockholders recognize that the Company reserves such rights.


 






    	3



    	 



    

 


1.7Termination.
This ARTICLE I, and the rights and obligations of the Stockholders under this ARTICLE I, shall terminate on the earliest of (i)
the date that Tengram’s beneficial ownership of the Common Stock (which, for purposes of such calculation, shall include
shares of Common Stock underlying the Debenture and Warrants) is less than 20% of the Fully Diluted Common Stock, (ii) the date
that Tengram and its Affiliates no longer own at least 50% of the shares of Common Stock (which, for purposes of such calculation,
shall include shares of Common Stock underlying the Debenture) acquired by Tengram pursuant to the Securities Purchase Agreement,
and (iii) the tenth (10th) anniversary of the date of the Original Agreement.


 


ARTICLE II 


PREEMPTIVE RIGHTS


 


2.1Equity Purchase Rights.


 


(a) The
Company hereby grants to Tengram, so long as Tengram is an “accredited investor” (as defined in Rule 501 of Regulation
D promulgated under the Securities Act) (the “Preemptive Stockholder”) the right to purchase its Pro Rata Portion
of all or any part of New Securities that the Company or any Subsidiary may, from time to time after the Closing, propose to sell
or issue for cash. The number or amount of New Securities which the Preemptive Stockholder may purchase pursuant to this Section
2.1(a) shall be referred to as the “Equity Purchase Shares.” The equity purchase right provided in this Section
2.1(a) shall apply at the time of issuance of any right, warrant or option or convertible or exchangeable security and not to the
conversion, exchange or exercise thereof. The Preemptive Stockholder may assign its rights to make such purchase to any other member
of its Stockholder Group.


 


(b) The
Company shall give written notice of a proposed issuance or sale described in Section 2.1(a) to the Preemptive Stockholder within
15 Business Days following any meeting of the Board at which any such issuance or sale is approved and at least 30 days prior to
the proposed issuance or sale. Such notice (the “Issuance Notice”) shall set forth the material terms and conditions
of such proposed transaction, including the proposed manner of disposition, the number or amount and description of the shares
proposed to be issued, the proposed issuance date and the proposed purchase price per share. Such notice shall also be accompanied
by any written offer from the prospective purchaser to purchase such New Securities.


 


(c) At
any time during the 30-day period following the receipt of an Issuance Notice, the Preemptive Stockholder shall have the right
to elect irrevocably to purchase its Pro Rata Portion of the number of the Equity Purchase Shares at the purchase price set forth
in the Issuance Notice and upon the other terms and conditions specified in the Issuance Notice by delivering a written notice
to the Company. Except as provided in the following sentence, such purchase shall be consummated concurrently with the consummation
of the issuance or sale described in the Issuance Notice. The closing of any purchase by the Preemptive Stockholder may be extended
beyond the closing of the transaction described in the Issuance Notice to the extent necessary to (i) obtain required approvals
of Government Entities and other required approvals and the Company shall use its commercially reasonable efforts to obtain such
approvals and (ii) permit the Preemptive Stockholder to complete its internal capital call process following the 15-day
notice period; provided that the extension pursuant to this clause (ii) shall not exceed 60 days.


 






    	4



    	 



    

 


(d) If
the Preemptive Stockholder fails to exercise fully the equity purchase right within the periods described above, the Company or
the applicable Subsidiary shall be free to complete the proposed issuance or sale of the New Securities described in the Issuance
Notice with respect to which the Preemptive Stockholder failed to exercise the option set forth in this Section 2.1 on terms no
less favorable to the Company or the applicable Subsidiary than those set forth in the Issuance Notice (except that the amount
of securities to be issued or sold by the Company may be reduced); provided that (x) such issuance or sale is closed within
120 days after the receipt by the Preemptive Stockholder of the Issuance Notice and (y) the price at which the New Securities
are Transferred must be equal to or higher than the purchase price described in the Issuance Notice. Such periods within which
such issuance or sale must be closed shall be extended to the extent necessary to obtain required approvals of Government Entities
and other required approvals and the Company shall use its commercially reasonable efforts to obtain such approvals. In the event
that the Company has not sold such New Securities within such 120-day period, the Company shall not thereafter issue or sell any
New Securities, without first again offering such securities to the Preemptive Stockholder in the manner provided in this Section
2.1.


 


(e)The
preemptive rights granted under this ARTICLE II shall terminate on the earliest of (i) the date that Tengram’s beneficial
ownership of the Common Stock (which, for purposes of such calculation, shall include shares of Common Stock underlying the Debenture)
is less than 20% of the Fully Diluted Common Stock, (ii) the date that Tengram and its Affiliates no longer own at least 50% of
the shares of Common Stock (which, for purposes of such calculation, shall include shares of Common Stock underlying the Debenture)
acquired by Tengram pursuant to the Securities Purchase Agreement, and (iii) the tenth (10th) anniversary of the date
of the Original Agreement.


 






    	5



    	 



    

 


ARTICLE III 


DEFINITIONS


 


3.1Certain Definitions.
For the purposes hereof, in addition to the terms defined elsewhere in this Agreement, (a) capitalized terms not otherwise defined
herein shall have the meanings set forth in the Securities Purchase Agreement and (b) the following terms shall have the following
meanings:


 


“Affiliate”
means, with respect to any Person, (i) any Person directly or indirectly Controlling, Controlled by or under common Control with
such Person, (ii) any Person directly or indirectly owning or Controlling 10% or more of any class of outstanding voting securities
of such Person or (iii) any officer, director, general partner or trustee of any such Person described in clause (i) or (ii).


 


“Agreement”
means this Amended and Restated Stockholders Agreement, as amended from time to time in accordance with Section 4.6.


 


“Applicable
Law” means all applicable provisions of (i) constitutions, treaties, statutes, laws (including the common law), rules,
regulations, ordinances, codes or orders of any Governmental Entity, (ii) any consents or approvals of any Governmental Entity
and (iii) any orders, decisions, injunctions, judgments, awards, decrees of or agreements with any Governmental Entity.


 


“Board”
means the Board of Directors of the Company.


 


“Business
Day” means a day other than a Saturday, Sunday or other day on which commercial banks in New York City are authorized
or required to close.


 


“Closing”
has the meaning set forth in the Recitals.


 


“Common Stock”
has the meaning set forth in the Preamble.


 


“Common Stock
Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.


 


“Company”
has the meaning set forth in the Preamble.


 


“Control”
means the power to direct the affairs of a Person by reason of ownership of voting securities, by contract or otherwise.


 


“Convertible
Debenture” means the Senior Secured Convertible Debenture Due January 31, 2015 and held by Tengram.


 


“Corporate
Opportunity” has the meaning set forth in Section 1.6.


 






    	6



    	 



    

 


“Equity Securities”
has the meaning set forth in the Recitals.


 


“Fully Diluted
Common Stock” shall mean all of the Common Stock of the Company, assuming conversion, exercise or exchange of all outstanding
convertible or exchangeable securities, options, warrants and similar instruments into or for Common Stock (regardless of whether
such convertible securities, options, warrants or similar securities are then convertible or exercisable, and without regard to
any limitations on exercise or conversion thereof).


 


“Group”
has the meaning assigned to such term in Section 13(d)(3) of the Exchange Act.


 


“Information”
means all information about the Company or any of its Subsidiaries that is or has been furnished to any Stockholder or any of its
Representatives by or on behalf of the Company or any of its Subsidiaries or any of their respective Representatives, and any other
information supplied by the Company in connection with the Purchase (whether written or oral or in electronic or other form and
whether prepared by the Company, its advisers or otherwise), together with all written or electronically stored documentation prepared
by such Stockholder or its Representatives based on or reflecting, in whole or in part, such information; provided that the term
“Information” does not include any information that (x) is or becomes generally available to the public through no
action or omission by any Stockholder or its Representatives or (y) is or becomes available to such Stockholder on a non-confidential
basis from a source, other than the Company or any of its subsidiaries, or any of their respective Representatives, that to the
best of such Stockholder's knowledge, after reasonable inquiry, is not prohibited from disclosing such portions to such Stockholder
by a contractual, legal or fiduciary obligation.


 


“New Securities”
means Common Stock or Common Stock Equivalents of the Company or of any Subsidiary other than (a) shares of Common Stock or options
to employees, officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority
of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established
for such purpose, (b) securities issued upon the exercise or exchange of or conversion of any securities of the Company issued
hereunder and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding
on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase
the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities, (c) securities
issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company,
provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its
subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall
provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing
in securities, and (d) securities issued to Tennman WR-T, Inc., pursuant to the exercise of its preemptive rights in accordance
with the Preemptive Rights and Board Nomineee Agreement.


 






    	7



    	 



    

 


“Permitted
Transferee” means as to any Stockholder: (i) the owners of such Stockholder in connection with any liquidation of, or
a distribution with respect to an equity interest in, such Stockholder (including but not limited to any distribution by a Stockholder
to its limited partners); or (ii) an Affiliate of such Stockholder; provided that in no event shall any “portfolio company”
(as such term is customarily used among institutional investors) of any Stockholder or any entity Controlled by any portfolio company
of any Stockholder constitute a “Permitted Transferee”. Any Stockholder shall also be a Permitted Transferee of the
Permitted Transferees of itself.


 


“Person”
means any individual, corporation, limited liability company, limited or general partnership, joint venture, association, joint-stock
company, trust, unincorporated organization, government or any agency or political subdivisions thereof or any Group comprised
of two or more of the foregoing.


 


“Preferred
Stock” shall mean shares of the Company’s Series A Preferred Stock issued to Tengram at the Closing.


 


“Pro Rata
Portion” means for the purposes of Section 2.1, on any issuance date for New Securities, the number or amount of New
Securities equal to the product of (i) the total number or amount of New Securities to be issued by the Company or its applicable
Subsidiary on such date and (ii) the fraction determined by dividing (A) the number of shares of Common Stock (which, for purposes
of such calculation, shall include shares of Common Stock underlying the Debenture) owned by such Preemptive Stockholder immediately
prior to such issuance by (B) the total number of shares of Common Stock outstanding (which, for purposes of such calculation,
shall include shares of Common Stock underlying the Debenture) on such date immediately prior to such issuance.


 


“Purchase”
has the meaning set forth in the Recitals.


 


“Representatives”
means with respect to any Person, any of such Person’s, or its Affiliates’, directors, officers, employees, general
partners, Affiliates, direct or indirect shareholders, members or limited partners, attorneys, accountants, financial and other
advisers, and other agents and representatives, including in the case of any Stockholder any person nominated to the Board or a
Committee by such Stockholder.


 


“Securities
Act” means the Securities Act of 1933, as amended from time to time, and the rules and regulations promulgated thereunder.


 


“Securities
Purchase Agreement” has the meaning set forth in the Recitals.


 






    	8



    	 



    

 


“Stockholder Group”
means, with respect to any Stockholder, such Stockholder and the Stockholder Group Members of such Stockholder. 


 


“Stockholder
Group Member” has the meaning set forth in Section 1.6.


 


“Stockholders”
has the meaning set forth in the Preamble.


 


“Subsidiary”
means each Person in which a Person owns or controls, directly or indirectly, capital stock or other equity interests representing
more than 50% of the outstanding capital stock or other equity interests.


 


“Tengram”
has the meaning set forth in the Recitals.


 


“Transfer”
means, directly or indirectly, to sell, transfer, assign, pledge, encumber, hypothecate or similarly dispose of, either voluntarily
or involuntarily, or to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer,
assignment, pledge, encumbrance, hypothecation or similar disposition of, any shares of Equity Securities owned by a Person or
any interest (including but not limited to a beneficial interest) in any shares of Equity Securities owned by a Person.


 


4.2 Terms Generally.
The words “hereby”, “herein”, “hereof”, “hereunder” and words of similar import
refer to this Agreement as a whole (including the Exhibits and Annexes hereto) and not merely to the specific section, paragraph
or clause in which such word appears. All references herein to Articles, Sections, Exhibits and Annexes and Schedules shall be
deemed references to Articles and Sections of, and Exhibits and Annexes to, this Agreement unless the context shall otherwise require.
The words “include”, “includes” and “including” shall be deemed to be followed by the phrase
“without limitation”. The definitions given for terms in this Article III and elsewhere in this Agreement shall apply
equally to both the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include
the corresponding masculine, feminine and neuter forms. References herein to any agreement or letter shall be deemed references
to such agreement or letter as it may be amended, restated or otherwise revised from time to time.


 


ARTICLE IV


MISCELLANEOUS


 


4.1Termination.
Subject to the early termination of any provision as a result of an amendment to this Agreement agreed to by the Company and the
Stockholders as provided under Section 4.6, this Agreement may be terminated only by the unanimous agreement of the Company and
Tengram. Nothing in this Agreement shall relieve any party from any liability for the breach of any obligations set forth in this
Agreement.


 


4.2Confidentiality.
Tengram agrees to, and shall cause its Representatives to, keep confidential and not divulge any Information, and to use, and cause
its Representatives to use, such Information only in connection with the operation of the Company and its Subsidiaries; provided
that nothing herein shall prevent Tengram from disclosing such Information (a) upon the order of any court or administrative agency,
(b) upon the request or demand of any regulatory agency or authority having jurisdiction over such party, (c) to the extent compelled
by legal process or required or requested pursuant to subpoena, interrogatories or other discovery requests, (d) to the extent
necessary in connection with the exercise of any remedy hereunder, (e) to its Representatives that in the reasonable judgment of
Tengram need to know such Information or (g) to any potential Permitted Transferee in connection with a proposed Transfer
of Equity Securities from Tengram as long as such transferee agrees to be bound by the provisions of this Section 4.2, provided
that, in the case of clause (a), (b) or ( c), Tengram shall notify the Company of the proposed disclosure as far in advance of
such disclosure as practicable and use reasonable efforts to ensure that any Information so disclosed is accorded confidential
treatment, when and if available.


 






    	9



    	 



    

 


4.3 Restrictions
on Other Agreements; Conflicts.


 


(a) Following
the date hereof, Tengram shall not enter into or agree to be bound by any stockholder agreements or arrangements of any kind with
any Person with respect to any Equity Securities that conflicts with the terms of this Agreement.


 


(b)The
provisions of this Agreement shall be controlling if any such provisions or the operation thereof conflict with the provisions
of the Company’s by-laws. Tengram covenants and agrees to vote its Common Stock (including Preferred Stock) and to take any
other action reasonably requested by the Company to amend the Company's by-laws or certificate of incorporation so as to avoid
any conflict with the provisions hereof.


 


4.4 Further
Assurances. Each party hereto shall do and perform or cause to be done and performed all such further acts and things, and
shall execute and deliver all such further agreements, certificates, instruments and documents, as any other parties hereto reasonably
may request in order to carry out the provisions of this Agreement and the consummation of the transactions contemplated hereby.


 


4.5 No Recourse.
Notwithstanding anything to the contrary in this Agreement, the Company and each Stockholder agrees and acknowledges that no recourse
under this Agreement or any documents or instruments delivered in connection with this Agreement, shall be had against any former,
current or future director, officer, employee, general or limited partner or member of any Stockholder or of any Affiliate or assignee
thereof, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation
or other Applicable Law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed
on or otherwise be incurred by any former, current or future officer, agent or employee of any Stockholder or any former, current
or future member of any Stockholder or any former, current or future director, officer, employee, partner or member of any Stockholder
or of any Affiliate or assignee thereof, as such for any obligation of any Stockholder under this Agreement or any documents or
instruments delivered in connection with this Agreement for any claim based on, in respect of or by reason of such obligations
or their creation.


 






    	10



    	 



    

 


4.6 Amendment;
Waivers, etc. This Agreement may be amended, and the Company may take any action herein prohibited, or omit to perform any
act herein required to be performed by it, only if any such amendment, action or omission to act, has been approved by the Company
and Tengram, provided that this Agreement may not be amended in a manner adversely affecting the rights or obligations of any Stockholder
which does not adversely affect the rights or obligations of all similarly situated Stockholders in the same manner without the
consent of such Stockholder. The failure of any party to enforce any of the provisions of this Agreement shall in no way be construed
as a waiver of such provisions and shall not affect the right of such party thereafter to enforce each and every provision of this
Agreement in accordance with its terms. Any Stockholder may waive (in writing) the benefit of any provision of this Agreement with
respect to itself for any purpose. Any such waiver shall constitute a waiver only with respect to the specific matter described
in such writing and shall in no way impair the rights of the Stockholder granting such waiver in any other respect or at any other
time.


 


4.7 Assignment.
Neither this Agreement nor any right or obligation arising under this Agreement may be assigned by Tengram without the prior written
consent of the Company or by the Company without the prior consent of Tengram, provided that any Stockholder may assign all or
a portion its rights (but not its obligations) hereunder to any member of its Stockholder Group that is or becomes a Stockholder.


 


4.8 Binding
Effect. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, successors
and permitted assigns.


 


4.9No Third
Party Beneficiaries. Nothing in this Agreement shall confer any rights upon any Person other than the parties hereto and each
such party’s respective heirs, successors and permitted assigns.


 


4.10 Notices.
All notices, requests, demands, waivers and other communications required or permitted to be given under this Agreement shall be
in writing and shall be deemed to have been duly given if (a) delivered personally, (b) mailed, certified or registered mail with
postage prepaid, (c) sent by reputable overnight courier or (d) sent by fax (provided a confirmation copy is sent by one of the
other methods set forth above), to the addresses set forth on the signature pages attached hereto (or to such other address as
the party entitled to notice shall hereafter designate in accordance with the terms hereof):


 


4.11 Severability.
Any term or provision of this Agreement which is invalid, illegal or unenforceable in any jurisdiction shall, as to that jurisdiction,
be ineffective to the extent of such invalidity, illegality or unenforceability without rendering invalid, illegal or unenforceable
the remaining terms and provisions of this Agreement or affecting the validity, illegality or enforceability of any of the terms
or provisions of this Agreement in any other jurisdiction. If any provision of this Agreement is so broad as to be unenforceable,
the provision shall be interpreted to be only as broad as is enforceable. Upon such determination that any term or other provision
is invalid, illegal or incapable of being enforced, the parties shall negotiate in good faith to modify this Agreement so as to
effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions
contemplated herein are consummated as originally contemplated to the fullest extent possible.


 






    	11



    	 



    

 


4.12 Headings.
The headings contained in this Agreement are for purposes of convenience only and shall not affect the meaning or interpretation
of this Agreement.


 


4.13 Entire
Agreement. This Agreement, together with the exhibits hereto, constitute the entire agreement and supersedes all prior agreements
and understandings, both written and oral, among the parties with respect to the subject matter hereof.


 


4.14 Governing
Law. This Agreement will be governed by and construed in accordance with the laws of the State of New York (regardless of the
laws that might otherwise govern under applicable principles or rules of conflicts of law to the extent such principles or rules
are not mandatorily applicable by statute and would require the application of the laws of another jurisdiction).


 


4.15Consent
to Jurisdiction. Each party irrevocably submits to the exclusive jurisdiction of (a) the Supreme Court of the State of New
York, New York County, and (b) the United States District Court for the Southern District of New York, for the purposes of any
suit, action or other proceeding arising out of this Agreement or any transaction contemplated hereby (and agrees not to commence
any such suit, action or other proceeding except in such courts). Each party further agrees that service of any process, summons,
notice or document by U.S. registered mail to such party’s respective address set forth or referred to in Section 4.10 shall
be effective service of process for any such suit, action or other proceeding. Each party irrevocably and unconditionally waives
any objection to the laying of venue of any such suit, action or other proceeding in (i) the Supreme Court of the State of New
York, New York County, and (ii) the United States District Court for the Southern District of New York, that any such suit, action
or other proceeding brought in any such court has been brought in an inconvenient forum.


 


4.16 Waiver
of Jury Trial. Each party hereby waives, to the fullest extent permitted by Applicable Law, any right it may have to a trial
by jury in respect of any suit, action or other proceeding arising out of this Agreement or any transaction contemplated hereby.
Each party (a) certifies and acknowledges that no representative, agent or attorney of any other party has represented, expressly
or otherwise, that such other party would not, in the event of litigation, seek to enforce the foregoing waiver, and (b) acknowledges
that it understands and has considered the implications of this wavier and makes this wavier voluntarily, and that it and the other
parties have been induced to enter into the Agreement by, among other things, the mutual waivers and certifications in this Agreement.


 






    	12



    	 



    

 


4.17Enforcement.
Each party hereto acknowledges that money damages would not be an adequate remedy in the event that any of the covenants or agreements
in this Agreement are not performed in accordance with its terms, and it is therefore agreed that in addition to and without limiting
any other remedy or right it may have, the non-breaching party will have the right to an injunction, temporary restraining order
or other equitable relief in any court of competent jurisdiction enjoining any such breach and enforcing specifically the terms
and provisions hereof. In the event that the Company or Tengram shall file suit to enforce the covenants contained in this Agreement
(or obtain any other remedy in respect of any breach thereof), the prevailing party in the suit shall be entitled to recover, in
addition to all other damages to which it may be entitled, the costs incurred by such party in conducting the suit, including,
without limitation, reasonable attorney's fees and expenses.


 


4.18 Counterparts;
Facsimile Signatures. This Agreement may be executed in any number of counterparts, each of which shall be an original, but
all of which together shall constitute one instrument. This Agreement may be executed by facsimile signature(s).


 


4.19 Removal
of Colin Dyne as a Party. The Company, Tengram and Dyne hereby acknowledge and agree that, as of the date of this Agreement,
Dyne is hereby removed as a party to this Agreement and the Original Agreement and shall have no further rights or obligations
hereunder or thereunder.


 






    	13



    	 



    

 





IN WITNESS WHEREOF,
the parties hereto have duly executed this Agreement by their authorized representatives as of the date first above written.


 


	SEQUENTIAL BRANDS GROUP, INC.	Address for Notice:
	 	 
	 	 
	By: /s/Yehuda Shmidman                         	1065 Avenue of Americas, Suite 1705
	Name: Yehuda Shmidman	New York, NY 10018
	Title: Chief Executive Officer	 
	 	 
	 	 
	TCP WR ACQUISITION, LLC	Address for Notice:
	 	 
	 	 
	By:  /s/William Sweedler                           	15 Riverside Ave
	Name: William Sweedler	Westport, CT 06880
	Title: Authorized Signatory	 
	 	 
	 	 
	 	 
	 	 
	 	 
	ACKNOWLEDGED AND AGREED	 
	 	 
	COLIN DYNE	 
	 	 
	 	 
	By:  /s/Colin Dyne                                     	 


 






    	14